Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis

Background Programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) have dramatically improved cancer therapy for many patients. Adverse kidney effects have been found to be an important complication but have unclear mechanisms. Methods We searched Embase, PubMed, and the Cochrane Library to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Han, Xu, Jinsheng, Bai, Yaling, Zhang, Shenglei, Cheng, Meijuan, Jin, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068624/
https://www.ncbi.nlm.nih.gov/pubmed/33409896
http://dx.doi.org/10.1007/s10637-020-01039-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068624/
https://www.ncbi.nlm.nih.gov/pubmed/33409896
http://dx.doi.org/10.1007/s10637-020-01039-5

Ejemplares similares